CA1293407C - Imaging systems employing photosensitive microcapsules containing 3-substituted coumarins and other photobleachable sensitizers - Google Patents

Abstract

Abstract Imaging systems employing photosensitive microcapsules having improved film speed are disclosed wherein the microcapsules contain a photosensitive composition in which the photoinitiator system includes a photobleachable sensitizer such as a 3-substituted coumarin compound; the invention is particularly useful in providing self-contained imaging systems which are sensitive at 390-500 nm but which can be photobleached to reduce background yellow; an imaging process including a photobleaching step following exposure and development is also disclosed.

Description

~29~4al7 Back~round of the Invention The present invention relates to an improved imaging system of the type employing photosensitive microcapsules.
Imaging systems employing photosensitive micro-capsules are described in commonly assigned U.S. Patents4,399,209 and 4,440,836 and commonly assigned Australian Patent No. 552,349 issued August 6, 1982 and pending Canadian patent application Serial No. 447,634, filed March 27, 1985. The imaging systems, in their simplest form, comprise an imaging sheet having a layer of photosensitive microcapsules coated on one surface. The internal phase of the microcapsules includes a photosensitive composition and, more particularly, a photocurable composition which cures by free radical addition polymerization. In the most typical embodiments, the internal phase also includes an image-forming agent such as a substantially colorless electron donating color former. Images are formed by image-wise exposing the layer of microcapsules to actinic radiation and subjecting the layer to a uniform rupturing force in the presence of a developer material.
U.S. Patent 4,399,209 discloses a transfer imaging system in which the developer material is provided on a support which is separate and distinct from the imaging sheet. After exposing the imaging sheet, it is assembled with the developer sheet and the two are passed together with their respective faces in contact between a pair of pressure rollers.
:
.~:

U.S. Patent 4,440,846 describes a self-contained system in which the developer is provided on the same surface of the support as the photosensitive microcapsules.
The aforesaid Australian Patent No. 552,349 and Canadian application Serial No. 477,634 describe full colour ima~ing systems in which three sets of microcapsules respectively containing cyan, magenta and yellow color formers are provided on one or separate supports and image-wise exposed using color separation techniques to provide a full color image. In one embodiment, the three sets of the microcapsules have distinct sensitivites such that they can be mixed and exposed on the surface of a single support using, for example, a Dunn matrix camera.
Summarv of the Invention Microcapsule formations which are sensltive in the region of 390 to 500 nm of the visible spectrum are yellow in color due to the spectral sensitivity of the internal phase and, more particularly, the photoinitiator system.
While this is not disadvantageous in a transfer imaging system wherein the image is formed on the developer or image-receiving sheet which is separate from the imaging sheet, it is a problem in self-contained systems because the image is formed directly on the imaging sheet. The presence of yellow microcapsules imparts a yellow tint to the background and aesthetically detracts from the image.
In accordance with the present invention, imaging sheets are provided containing a photobleachable sensitizer in the internal phase and, more particularly, a 3-substituted coumarin compound. These sensitizers are ' ~Z~ 407 sensitive in the 390-500 portion of the spectrum and impart a yellow hue to the imaging sheet bv'c for the fact that they can be bleached upon exposure to fluorescent (ultraviolet) light following develop~en1:. By incorporating 3-substituted coumarin compounds or other photobleachable 390-500 nm sensitizers in the internal phase of the microcapsules, a self-conta:ined imaging sheet can be provided which, while initially yellow or yellow tinged, can be bleached by exposure to fluorescent light following development to obtain a whiter background and improved image quality.
~ he use of 3-substituted coumarin compounds as sensitizers in photosensitive microencapsulated i~aging systems is important not only because the compounds are photobleachable but also because they improve imaging speed. Thus, it has been found that it is advantageous to use these compounds in both self-contained and transfer imaging systems for improved film speed.
One object of the present invention is to provide an improved self-contained imaging system which i~cIudes a photoinitiator system in the internal phase containing a photobleachable sensitizer.
Another object of the present invention is to provide a self-contained imaging system including a photobleachable sensitizer which is sensitive in the range ~ of 390 to 500 nm and which can be photobleached following ; exposure and development to provide a white or nearly white background.
Still another object of the presen~ invention is to provide an imaging process wherein following exposur~
and developmen~ of a self-contained imaging sheet in ~913~0~

accordance with the present invention, the sheet is - uniformly exposed to ultraviolet radiation to bleach the sensitizer and whiten the background.
Still another object of the present invention is to provide an imaging system employing photosensitive microcapsules having improved film speed wherein the microcapsules include a 3-substituted coumarin compound as part of the photoinitiator system. This imaging system can be a transfer or self-contained imaging system.

Definitions The term "microcapsule" as used herein includes both microcapsules having a discrete capsule wall as well as so-called open phase syste~s in which the photosensitive composition is dispersed in a binder, The term "actinic radiation" as used herein includes the full spectrum of electromagnetic radiation as well as x-ray, ion beam, and gamma radiation.

Detailed Description of the_Invention The imaging systems of the present invention can be prepared by following the teacbings in U.S. Patents 4,399,209 and 4,440,846, Australian Patent No. 552,349 and Canadian patent application Serial No. 620,994.

The present invention is useful in providing a blue light-sensitive imaging sheet having improved film speed and, more particularly, to providing a blue light sensitive self-contained sheet having both improved film speed and improved background color. It is also useful in providing blue light sensitive imaging sheets which are ~3~07 developed by sequentially rupturing the microcapsules and applying a developer composition to the surface of the sheet wherein images are formed on the imaging sheet itself and reduced background yellowing is desired. Full color systems including blue-sensitive microcapsules are also within the scope of the present invention.
While various photobleachable sensitizers sensitive to blue light can be used in the present invention, a particularly useful class of sensitizers is 3-substituted coumarin compounds. Representative examples of 3-substituted coumarin compounds useful in the present invention are described in U.S. Patent 4,147,552 to Eastman Kodak Company and can be represented by the formula tI):

; R
~ Q
~0 ~1~

~ R

wherein Q is -CN or -Z-Rl; z is carbonyl, sulfonyl, sulfinyl or arylenedicarbonyl; Rl is hydroxy, an alkenyl group having 2 to 12 carbon atoms (e.g., vinyl, styryl, etc); an alkyl group having 1 to 12 carbon atoms ~e.g., methyl, ethyl, propyl, amyl, heptyl, etc.); an alkoxy group having 1 ~o 12 carbon atoms (e.g., methoxy, ethoxy;
butoxy, etc.); an aryl group having 6 to 10 nuclear carbon atoms le.g., phenyl, naphthyl, etc.); a carbocyclic group havins 5 to 12 carbon atoms (e.g., cyclohexyl); or a heterocyclic group having 5 to 15 nuclear carbon and ~;
. . . .

lZ~3~0~

hetero atoms (e.g., 3-pyridyl, 4-pyridyl, furyl, thienyl, pyridinium, or coumarinyl);
R2, R3 t R4 and R5 each independently represent hydrogenr an alkoxy group having l to 6 carbon atoms, a dialkylamino group with each alkyl group having l to 4 carbon atoms (e.g., diethylamino), a halogen atom (e.g., chloro, iodo, etc.), an acyloxy group, a nitro group, a 5- or 6-membered heterocyclic group, or a group having th~ formula (II):

~ R9- (II) wherein R9 is an alkylene group having from l to 5 carbon atoms:
R6 is hydrogen, an alkyl group having l to 4 carbon atoms, an aryl group having 5 to lO nuclear carbon atoms, or an acyl group having 2 to 6 carbon atoms (e.g., acetyl);
and wherein two or three of R2, R3, R4, and R5 and the nuclear carbon atoms to which they are attached can together form a fused ring or fused ring system, each ring being a 5- or 6-membered ring.
In accordance with the most preferred embodiments of the invention Q is -Z-Rl, z is carbonyl, and Rl is a heterocyclic group, carbocyclic group, or an aryl group.
3-substituted coumarin compounds which are useful in the present invention include:

~Z~34~)7 : - 7 -7-diethylamino-5',7'-dimethoxy-3,3'-carbonylbiscoumarin;
3,3'-carbonylbis(5~7-dimethoxycoumarin);
7-diethylamino-3,3'-carbonylbiscoumarin;
7-diethylamino-7'-methoxy-3,3'-carbonylbiscoumarin;
7-diethylamino-7'-dimethylamino-3,3'-carbonylbis-coumarin;
7-diethylamino-3-thenoylcoumarin;
3-(2-coumariloyl)-7-diethylaminocoumarin;
3-cinnamoyl-7-diethylaminocoumarin;
3[(4-dimethylamino)-cinnamoyll-7-diethylamino-coumarin.
These compounds can be prepared in accordance with the teachings in U.S. Patent 4,147,552.
Other photobleachable sensitizers include 9,10-phenantherenequinones such as 2-methyl-9,10-phenanthrenequinone and 2-dodecyl-9,10-phenanthrenequinone;
camphorquinone and the compounds c~ ~3 o ~9 e~

~(C~

:.

~ ~ - . . .

, .
.,.
, ` ~2~3~07 The photobleachable sensitizer can be used alone or in a photoinitiator system including other photoinitiators such as aromatic ketones and diketones, e.g., 2,2-dimethoxy-2-phenylacetophenone (e.g., Irgacure 651 of Ciba-Geigy); l-hydroxycyclohexyl phenyl ketone (e.g.~ Irgacure 184 of Ciba-Geigy), 2,2-cliethoxy-acetophenone; ethyl 4-dimethylaminobenzoate, thioxanthones, xanthones; benzoin alkylethers such as benzoin propyl ether and benzoin isobutyl ether, etc.
Preferred photoinitiator systems include co-initiators which function as hydrogen donors. Useful hydrogen donors include tertiary amino compounds and, more particularly, dialkylanilines such as N,N-dimethylanilines (e.g.

2,6,N,N-tetra-methylaniline, 4-t-butyl-N,N-dimethylaniline, etc.l.
- The amount of sensitizer used in the present invention will vary with the nature of the ethylenically unsaturated compound, the size of the microcapsules and other factors. Generally, in the case of a 3-substituted ketocoumarin compound it is used in an amount of about 3 X
10 6 to 6 X 10-4 moles per gram of photopolymerizable material.
A preferred example of a photosensitive composition in accordance with the present invention is:
Trimethylolpropane triacrylate 200 parts 3-Cinnamoyl-7-diethylaminocoumarin 0.4 parts Ethyl-4-dimethylamino benzoate8 parts 2,6-Diphenyl-4-(4'-dimethylamino-30 ph~nyl)pyridine 20 parts lZ93407 With the exception of the inclusion of a photobleachable sensitizer, the microcapsules of the present invention can be prepared as described in the aforementioned patentsO In a full color imaging system it is often desirable to addi~ionally incorporate an absorber compound such as an ultraviolet absorber in the internal phase to narrow the spectral sensitivity of the microcapsules. Useful absorbers are described in commonly assigned Canadian Application Serial No. 477,634.
The most common examples of photopolymerizable materials are compounds which are curable by free radical addition polymerization such as ethylenically unsaturated compounds, e.g~, compounds containiny one or more terminal or pendant vinyl or allylic groups. Such compounds are well known in the art and include acrylic and methacrylic esters of polyhydric alcohols such as trimethylolpropane, pentaerythritol, and the like. Representative examples include ethylene glycol diacrylate, ethylene glycol dimethacrylate, trimethylolpropane triacrylate (TMPTA), pentaerythritol tetraacrylate, pentaerythritol tetramethacrylate, hexanediol-1,6-dimethacrylate, and diethyleneglycol dimethacrylate.
In accordance with one embodiment of the present invention, the radiation sensitive composition may additionally include a polythiol to increase the film speed of the microcapsules. Useful polythiols include ethylene glycol bis (thioglycolate), ethylene glycol bis (~-mercapto-propionate), trimethylolpropane tris (thioglycolate), pentaerythritol tetrakis (thioglycolate) and the most preferred pentaerythritol tetrakis ~B-mercaptopropionate~ and trimethylolpropane trir , 3a~07 (~-mercapto-propionate), and mixtures thereof. These compounds are commercially available. Certain polymeric polythiols such as polypropylene ether glycol bis (~-mercaptopropiona~e) which is prepared by esterification of polypropylene ether glycol may also be useful.
Various oligomers or polymers can also be used in the presen~ invention to improve the film speed of the microcapsules. These materials should be soluble in the photosensitive composition and not interfere with the photopolymeriæation reaction. Reactive oligomers contain terminal or pendant ethylenic unsaturation and inclucle urethane, ester and epoxy based reactive acrylate, methacrylate, vinyl and allyl prepolymers. Use~ul non-reactive oligomers are polymers which are solid or semisolid at room temperature but soluble in the unreacted photosensitive composition. Representative examples of some commercially available oligomers or polymers which are useful in the present invention include reactive materials such as diallyl o-phthalate prepolymer (Polysciences~, Uvithane* 893 ~Morton Thiokol, Inc.~, Ebercryl*270 (Virginia Chemicalsj and non-reactive materials such as ethyl cellulose, or Lucite.*
An image-forming agent is associated with the photosensitive microcapsules of the present invention on the imaging sheet. Preferably, the image-forming agent is present in the internal phase of the microcapsules however, where the unexposed or unreacted internal phase is capable of dissolving or otherwise mobilizing the image-forming agent, it may be outside the capsule, in the same layer as the microcapsules are incorporated or in a layer contiguous with the layer containing the microcapsules.

* trade marks Various image-forming agents can be used in the present invention including dyes and pigments, however, the most typical and preferred image-for~er is a chromogenic material such as a substantially colorless electron donating compound of the type used in pressure-sensitive carbonless copy paper. These compounds are well known in the art and react with acidic developers to generate color images. Useful examples include compounds such as those described in U.S. Patent. No.
3,985,376 to BASF.
The color former is incorporated in the internal phase in an amount sufficient to produce a visible image of the desired density upon reaction with a developer or upon transfer. In general, the color former is present in an amount of approximately 0.5 to 20% by weight based on the weight of the internal phase. A preferred range is about 2 to 10% by weight. Transfer imaging materials usually contain about 6% by weight of the color former whereas self-contained materials contain about l.5 to 3 by weight of the image-forming agent. The relative amounts of the cyan, magenta and yellow color formers in the microcapsules in a full color system are adjusted to provide satisfactory color balance. In conjunction with this, the relative amounts of the microcapsules in the coating composition can be adjusted to improve color balance.
In addition to the photosensitive composition, the internal phase may additionally include a diluent oil. Inclusion of the oil often improves mid tone gradation in visual images. Preferred diluent oils are weakly polar solvents having boiling points above l70C

:~Z~34~7 and preferably in the range of 180 to 300C. Examples of carrier oils are alkylated biphenyls ~e.g., monoisopropyl-biphenyl), polychlorinated biphenyls, castor oil, mineral oil, deodorized kerosene, naphthenic mineral oils, dibutyl phthalate, dibutyl fumerate, brominated paraffin and mixtures thereof. Alkylated biphenyls and kerosene are generally less toxic and preferred~ The amount of diluent oil incorporated in the microcapsules wiL1 depend upon the photographic characteristics that are desired in the photosensitive materials. Typically, the diluent oil is used in an amount of approximately 10 to 20% by weight based on the weight of the internal phase.
The photosensitive microcapsules of the present invention can be formed using known encapsulation techniques. The photosensitive composition and associated agents can be encapsulated in hydrophilic wall-forming materials such as gelatin-type materials (see U.S. Patent Nos. 2,730,456 and 2,800,457 to Green et al) including gum arabic, polyvinyl alcohol, carboxy-methyl-cellulose;
resorcinol-formaldehyde wall formers (see U.S. Patent No.
3,755,190 to Hart et al); isocyanate wall-formers (see U.S. Patent No. 3,914,511 to Vassiliades); isocyanate-polyol wall-formers (see U.S. Patent No. 3,796,669 to Kirintani et al); urea formaldehyde wall-formers, particularly urea-resorcinol-formaldehyde in which oleophilicity is enhanced by the addition of resorcinol (see U.S. Patent Nos. 4,001,140; 4,087,376 and 4,089,802 to Foris et al); and melamine-formaldehyde resin and hydroxypropyl cellulose (see commonly assigned U.S. Patent ~o. 4,025,455 to Shackle~. Urea-formaldehyde microcapsules are preferred for use in the present ~Z93~0~
~ - 13 -invention. Methods for producing urea formaldehyde capsules which are particularly useful are described in U.S. Patents 4,251,386 and 4,138,362.
The mean size of the microcapsules of the present invention generally ranges from approximately 1 to 25 microns. As a general rule, image resolution improves as capsule size decreases except that if the capsule size is too small, the capsules may disappear in the pore or fiber struc~ure of some substrates.
The microcapsules of the present invention can be used to form either transfer or self-contained, monochromatic or full color imaging systems. A detailed description of transfer materials can be found in U.S.
Patent No. 4,399,209. Self contained systems are the subject of co~monly assigned U.S. Patent 4,440,846.
Illustrative examples of developers useful with electron donating type color precursors mentioned above are clay minerals such as acid clay, active clay, attapulgite, etc.; organic acids such as tannic acid, gallic acid~ propyl gallate, etc.; acid polymers such as phenol-formaldehyde resins, phenol acetylene condensation resins, condensates between an organic carboxylic acid having at least one hydroxy group and formaldehyde, etc.;
metal salts or aromatic carboxylic acids such as zinc salicylate, tin salicylate, zinc 2-hydroxy naphthoate, zinc 3,5 di-tert-butyl salicylate, zinc 3-cyclohexyl-5-( a, ~-dimethylbenzyl) salicylate (see U.S. Patents 3,864,146 and 3,934,070), oil soluble metal salts or phenol-formaldehyde novolak resins (e.g., see U.S. Patent Nos. 3,672,935; 3,732,120 and 3,737,410) such as zinc modified oil soluble phenol-formaldehyde resin as .

~293~)7 disclosed in U.S. Patent No. 3,732,120, zinc carbonate etc~ and mixtures thereof.
The most common substrate for the photosensitive material of this invention is paper. Th paper may be a commercial impact raw stock, or a special grade paper such as cast-coated paper or chrome-rolled paper. Transparen~
substrates such as polyethylene terephthalate and translucent substrates can also be used in this invention.
Imaging sheets in accordance with the present invention can be exposed and developed by the imaging processes described in the aforementioned patents and applications which have been incorporated by reference.
More specifically, images are formed by image-wise exposing the imaging sheets to actinic radiation and ~ubjecting the microcapsules to a uniform rupturing force. ~here the microcapsules include a chromogenic material in the internal phase (or the chromogenic material is otherwise associated with the microcapsules such that release of the inteenal phase from the microcapsules controls the image) the microcapsules are preferably ruptured in the presence of a developer material which is capable of reacting with the chromogenic material and forming a color image. In transfer systems, the developer is present on a separate sheet whereas in self-contained systems it is present on the imaging sheet itself in the same layer as the microcapsules or in a separate contiguous layer~ In accordance wi~h a specific embodiment of the invention, images are formed on self-contained imaging sheets by image-wise exposing them 3Q to actinic radiation and subjecting ~he sheet to a uniform rupturing orce. Then, following development, the sheet ~3~0~

is uniformly exposed to ultraviolet radiation (e.g., fluorescent lightingl whereupon the sensitizer is bleached and an image having a brighter, whiter background is obtained. Alternatively, after the microcapsules are ruptured, developer can be applied to the imaging sheet such as by dusting the sheet with a dry developer composition.
In accordance with the present invention, microcapsules can be ruptured by passing the imaging sheet (in combination with a developer sheet in the case of a transfer system) through the nip between two pressure rollers. Alternativey, other means such as ultrasonic vibration, solvent vapor exposure, or peeling development can be used. Another means useful in developing the imaging sheets is by means of a so-called burnishing roller as described in U.S. Patent No. 4,448,516.
The present invention is illustrated in more detail by the following non~limiting examples:
E amples The photosensitive microcapsule formulations described in this application were prepared using the encapsulation procedure set forth below. This technique consists of dispersion of the aqueous insoluble internal phase into an aqueous external phase, followed by addition of capsule wall forming materials to the prepared emulsion. The external phase components, including the encapsulation materials, are identical for the four examples given and are:

lZ93~0~
:- 16 -104.0 9 - Distilled ~2 3.1 g - Pectin ~grade 1, citrus) 24.8 g - 18.5~ (W/W) Aqueous base hydrolyzed Isobam 0.1 g - Quadrol (an adduct of propylene oxide and ethylenediamine) 16.6 g - 50~ tW/W) Aqueous urea 5.8 g - 13.8~ tW/W) Aqueous resorcinol 21.4 g - 37~ (W/W) Aqueous ormaldehyde 10.6 9 - 5.66% (W/W) Aqueous ammonium sulfate 2.8 9 - Sodium bisulfite The internal phase compositions of the four examples given are identical except for the specific initiator. The invariant components are as follows:

50.0 g - Trimethylolpropane triacrylate (TMPTA) ; 2.0 9 - Ethyl,4-dimethylaminobenzoate (Quanticure EPD) 3.0 g - 1,1-Bis(4-dimethyaminophenyl)-5-dimethylamino-3-oxophthalan 1.679 - Trifunctional isocyanate adduct of trimethylolpropane and 2,4 toluene diisocyanate ~S~-50) 3.339 - Trifunctional trimer of 1,6-hexanediisocyanate (N-100) The examples varied by the inclusion in the internal phase of the photoinitiators indicated below:

~' '': '' ' , ' 1~93~7 Example 1 0.23g - 7-Diethylamino-3-thenoylcoumarin 0.109 - 7-Diethylamino-3-cinnamoylcoumarin Example 3 0.509 - 9,10-Phenanthrenequinone Exam~le 4 10.0 9 - 9-Fluorenone Procedure _ _ .
A 600 ml stainless steel beaker equipped with a Servod~ne overhead stirrer fitted with a six-bladed, 45 pitch turbine impeller and positioned upon a variable temperature hotplate was char~ed with the water and Isobam components of the external phase mixture. To this stirred mixture was added, by continuous slow sifting, the pectin component. After approximately twenty minutes of stirring the mixture appeared homogeneous and the p~ was adjusted to 4.0 by dropwise addition of 20% (W/W) aqueous sulfuric acid. At this time the Quadrol was added in one portion.
The stirring speed was adjusted to 3000 RPM and the specific internal phase solution (Examples 1 through 4~, prepared by sequential addition of the other internal ~ phase components, excepting the trifunctional isocyanate ; oligomers~ to TMPTA with vigorous stirring and heating to 80C, followed by addition and mixing of the isocyanates 1 to 2 minutes prior to use, was added in a thin continuous stream over a 10 to 15 second period. After a 10-minute emulsification period the stirrer ~peed was reduced to 2000 RPM and the aqueous solutions of urea, resorcinol, formaldehyde and ammonium sulfate were added, in the stated order, at 2-minute intervals. Subsequently, the encapsulation mixture was heated to 65C using in combination the hotplate and an impinging blast of hot air. Upon reaching 65C, this temperatuee was maintained with the hotplate alone~ Af~er a 2-hour cur ing per iod, the encapsulation mixture was allowed to cool and the pH
was adjusted to 9.0 by dropwise addition of 20% (W/W) aqueous sodium hydroxide. Addition of sodium bisulfite completed the encapsulation.
The individual microcapsule batches were diluted to 22% total solids with 2.5% (W/W) aqueous Klucel L and coated on 80 lb Black and White Glossy ~The Mead Corporation) paper using a number 12 wire~wound rod. The Samples were allowed to age overnight, placed in a 90C
forced air oven for 1 hour and allowed to cool to room temperature before evaluation.
Test exposures of each coated example were made througn a Stauffer step tablet (0.10 density increments) in contact with the photosensitive layer. The exposure times were 64 seconds for all samples evaluated. A
uniform flux of light was provided by a closely spaced planar array of four lS watt cool white fluorescent bulbs centered parallel to and at a distance 6 inches from the photosensitive surface. Each test sample was pressure calendered active surface to active surface against an acidic developer sheet and the resultant image densities were measured using a Macbeth TR927 Densitometer. The results of the evaluations are shown in Table 1. As can be seen from this data, Examples 1 and 2, which contain 3-ketocoumarin compounds, are clearly superior initiators as compared ~ith the sensitizers used in E3xamp1es 3 and 4.

I
.
?

~2~3~07 19 ~,;

Table 1 _ _ Step Number_ Example D90 D10 1 19.5 16.7 2 21.5 17.7 3 6.9 3.3 4 8.2 4.7 Reference Example To illustrate ~he photobleachable character of various sensitizers useful in the present invention, microcapsules prepared as in Examples 1-4 above but containing the sensitizers shown ln Table 2 were coated on a sheet of white frosted glass. Theough this support, the photoactive surfaces of the samples were exposed to light from two ~0 watt cool white fluorescent bulbs at a ; distance of 2 1/2 inches. The densities of the initial ; yellow shades as well as the bleached densities were measured with a Macbeth Model TR 924 densitometer using the blue filter setting. The minimum achievable density was assumed to be equal to the density of the substrate paper, which was typically in the range of 0.08 to 0.09 density units. The microcapsule batches were not image-wise exposed or deveIoped prior to the fading study.
Density of the samples was measured immediately before fading exposure, at 5 minute intervals up to 25 minutes, and at 90, 180, and 300 minutes total cumulative exposure. As can be seen from ~hese data listed in Table 3, all of the samples bleached significantly, many within 5 minutes total exposure.

, :~L2~3~

.
Table 2 ~, ~ O ~ ~, ~C~C~C~

Sensitiz~r Zl Xl, Yl X2 ~ Y2 n Z2 4-N (C~3) 2-O-CI~O -- 0 --2 4-N~C2Hs1~ n -O-C=O 1 41-N~C2H5~2 3 4--OCE13 9~ n 11 4 ~--OC~3 4 4~N(C2Hs)2 a n ~ 4~ 961 (-OCH3)2 ~ n ~ n 41--OC~13 6 5~ I n u __ 7 ~ n _ _ 8 s~ Il H ~ H
g n ~ Impure Cm ~ n 11 ~I n n 1 4 I-N (C}13) 2 12 w 1I N n 3 ~--Cl 13 n 4 ~--Cl 14 ~ n a 51 ~ 6 ~CH=CH-CH=CH
~ ~ n ~ 4 ~ ~ 5 1 -CH=CH-CH=C
16 4~ C~3) 2 ~pH H~ n 4 ~ -N ~ 3~ 2 17 a w __ O n :
:' - . - 21 -Table 2 (Cont'd) 390 nm to 500 nm Sensiti ers 19 ~-nCIa~ar ~ N, ~CI13 :; 0 21 ~C~3~

~ 3 ~ (C N~)a ~; .

Table 3 390 nm to 500 nm Sensitizer Photobleachable_D t Sensitizer Exposure Timè (mlnutes) No. 0 5 10 25 90 180 300 1 0.14 0.12 O.lj 0.13 0.11 0.11 0~1 2 0.32 0.21 0.21 0.17 0.15 0.13 ~.12 3 0.31 0.17 0.17 0.16 0.14 0.13 0.12 4 0.24 0.14 0.16 0.14 0.13 0.11 0.10 0.58 0.39 0.37 0.31 0.25 0.~2 0.1~
6 0.34 0.26 0.24 0.22 0.20 0.19 0~18 7 0.43 0.32 0.30 0.22 0.18 0.16 0.13 8 0.44 0.24 0.23 0.22 0.18 0.17 0.17 0.24 0.13 0.12 0.11 0.11 0.11 0.12 0.29 0.18 0.18 0~17 0.16 0.15 0.15 9 0.28 0.16 0.13 0.12 0.11 0.10 0.09 0.33 0.18 0.18 0.15 0.14 0.12 0.11 11 0.95 0.~2 0.28 0.25 0.20 0.16 ~.13 12 0.38 0.15 0.15 0.11 ~.11 0.09 O.og 13 0.31 0.12 0.11 0.10 0.10 0.09 0.09 14 0.25 0.16 0.14 0.14 0.13 0.11 0.11 0.51 0.25 0.24 0.23 0.21 0.16 0.14 16 0.76 0.73 0.62 0.44 0.33 0.30 0.28 17 0.26 0.17 0.15 0.15 0.14 ~.14 ~.15 0.48 0.44 0.38 0.31 0.28 0.28 0.28 18 0.18 0.13 0.12 0.12 0.13 0.13 0.12 0.20 0.17 0.17 0.17 0.17 0.18 0.19 0.16 O.I2 0.12 0.12 0.12 0.12 0.12 1~ 0.21 0.17 0.17 0.17 0.16 0.14 0.15 0.75 0.55 0.40 0.30 0.21 0.17 0.17 21 0.61 0.59 0.60 0.5g 0.53 0.53 0.45 0.58 0.60 0.60 0.57 0.48 0.38 0.30 22 0.24 0.25 0.25 0.25 0.18 0.12 0.12 3~

Having described the invention i.n detail and by : reference to preferred embodiments thereof, it will be apparent that modifications and variations are possible without departing from the scope of the :invention defined in the appended claims.
What is claimed is:

Claims (17)

1. An imaging sheet comprising a support having on a surface thereof a layer containing photosensitive microcapsules having an image-forming agent associated therewith, said microcapsules including in the internal phase thereof a free radical addition polymerizable material and a photoinitiator system including a photobleachable sensitizer, said sensitizer being a 3-substituted coumarin compound sensitive in the range of 390 to 500 nm.

2. The imaging sheet of claim 1 wherein said microcapsule has discrete capsule walls.

3. The imaging sheet of claim 2 wherein said free radical addition polymerizable material is an ethylenically unsaturated compound.

4. The imaging sheet of claim 3 wherein said image-forming agent is a substantially colorless electron donating color former and is present in said internal phase.

5. The imaging sheet of claim 4 wherein said 3-substituted coumarin is represented by the formula (I):

(I) wherein Q is -CN or -Z-R1; Z is carbonyl, sulfonyl, sulfinyl or arylenedicarbonyl; R1 is hydroxyl, an alkenyl group; an alkoxy group; an alkyl group; an aryl group; a carboxyclic group or a heterocyclic group;
R2, R3, R4 and R5 each independently represent hydrogen, an alkoxy group, a dialkylamino group, a halogen atom, a acyloxy group, a nitro group, a 5- or 6-membered heterocyclic group, or a group having the formula (II):

(II) wherein R9 is an alkylene group;
R6 is hydrogen, an alkyl group or an aryl group;
and wherein two or three of R2, R3, R4 and R5 and the nuclear carbon atoms to which they are attached can together form a fused ring or fused ring system, each ring being a 5- or

6-membered ring.

6. The imaging sheet of claim 5 wherein:
said coumarin is a ketocoumarin wherein Q is -Z-R1 and Z is carbonyl.

7. The imaging sheet of claim 6 wherein said coumarin is substituted at the 5- or 7-position with an alkoxy group or a dialkylamino group.

8. The imaging sheet of claim 7 wherein said coumarin is used in said photoinitiator system in combination with an N,N
dialkylaniline compound as a hydrogen donor.

9. The imaging sheet of claim 5 wherein said sheet includes a developer material co-deposited with said microcapsules on the surface thereof, said developer being capable of reacting with said image-forming agent and producing a color image.

10. A process for forming images which comprises:
image-wise exposing to actinic radiation a self-contained imaging sheet comprising a support having on a surface thereof a layer containing photosensitive microcapsules and a developer material, said microcapsules having an image-forming agent associated therewith, and including a free-radical addition polymerizable material and a photoinitiator system including a 3-substituted coumarin compound as a photobleachable sensitizer in the internal phase of said system, said developer material being capable of reacting with said image-forming agent and producing a color image;
subjecting said imaging sheet to a uniform rupturing force; and uniformly exposing said imaging sheet to radiation such that said photobleachable sensitizer is bleached.

11. The process of claim 10 wherein said microcapsules have discrete capsule walls.

12. The process of claim 11 wherein said free-radical addition polymerizable material is an ethylenically unsaturated compound.

13. The process of claim 12 wherein said image-forming agent is a substantially colorless color former and is present in said internal phase.

14. The process of claim 12 wherein said 3-substituted coumarin is represented by the formula (I) (I) wherein Q is -CN or -Z-R1; Z is carbonyl, sulfonyl, sulfinyl or arylenedicarbonyl; R1 is hydroxyl, an alkenyl group; an alkyl group; an alkoxy group; an aryl group: a carboxyclic group or a heterocyclic group;
R2, R3, R4 and R5 each independently represent hydrogen, an alkoxy group, a dialkylamino group, a halogen atom, an acyloxy group, a nitro group, a 5- or 6-membered heterocyclic group, or a group having the formula (II):
(II) wherein R9 is an alkylene group:
R6 is hydrogen, an alkyl group or an aryl group;
and wherein two or three of R2, R3, R4 and R5 and the nuclear carbon atoms to which they are attached can together form a fused ring or fused ring system, each ring being a 5- or 6-membered ring.

15. The process of claim 12 wherein:
said coumarin a ketocoumarin wherein Q is -Z-R1 and Z
is carbonyl.

16. The process of claim 15 wherein said coumarin is substituted at the 5- or 7-position with an alkoxy group or a dialkylamino group.

17. The process of claim 16 wherein said coumarin is used in combination with an N,N-dialkylaniline compound.